Skip to main content
. 2022 Jun 18;10(6):1441. doi: 10.3390/biomedicines10061441

Figure 1.

Figure 1

Molecular mechanisms of CTLA-4 and PD-1 inhibitory T-cell activation. Reprinted from “Blockade of CTLA-4 or PD-1 Signaling in Tumor Immunotherapy”, by BioRender.com (2022) (accessed on 6 March 2022). Retrieved from https://app.biorender.com/biorender-templates (accessed on 6 March 2022).